Otsi
Otsi
Figure 1. Coomassie-stained SDS-PAGE analysis of monoclonal antibody to SARS-CoV-2 Spike S1, clone 8E5. 4-12% gradient gel is used for analysis. Lane 1. Monoclonal antibody to SARS-CoV-2 Spike S1, clone 8E5 (-DTT). Lane 2. Size Marker. Lane 3. Monoclonal antibody to SARS-CoV-2 Spike S1, clone 8E5 (+DTT). Lane 4. Size Marker.
Figure 2. HPLC analytical SEC for final product.
Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.
Catalogue #
R1-163-100
Name
Human IgG1-lambda antibody to SARS CoV-2 Spike S1 (clone 8E5)
Target
SARS-CoV-2 virus
Target Description
SARS-CoV-2 virus (PBMCs isolated from patients recovered from SARS-CoV-2 infection, antibodies discovered by using HybriFree Technology).
Clonality
Human monoclonal
Clone
8E5
Class
hIgG1
Reactivity
SARS-CoV-2 Spike S1
Dissociation constant (KD)
1.0 x 10-12 M (measured against SARS-CoV-2 Trimeric Spike protein)
9.70 x 10-9 M (measured against SARS-CoV-2 Spike S1 protein)
Application
ELISA
ELISA:
indirect ELISA 0,02-0,04 ng/ml
Purification
Protein A affinity chromatography following desalting
Buffer
PBS pH 7.4
Shipping
Shipped at ambient temperature.
Storage
Store at +4 °C. Avoid multiple freeze-thaw cycles.
This product is for research use only
TECHNICAL ASSISTANCE
Please refer any technical questions to
technical.support@icosagen.com
© 2024 Icosagen
